Watkins Tim
CMO & Head of Development
Watkins Tim has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Watkins Tim is listed as CMO & Head of Development at Contineum Therapeutics, Inc. Inside the rolling window, Watkins Tim reported no open-market purchases and 4 open-market sales totaling $323K in CTNM. The largest disclosed transaction in the window is a sale of 10,833 CTNM shares on Jun 30, 2026, worth $174K.
Companies traded
Other insiders at CTNM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$323K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Watkins Tim made?
Watkins Tim has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Watkins Tim trade?
Watkins Tim has filed SEC Form 4 disclosures for 1 company, including CTNM.
When was Watkins Tim's most recent SEC Form 4 filing?
Watkins Tim's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Watkins Tim's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Watkins Tim is listed as CMO & Head of Development.
What is Watkins Tim's total buy and sell value in the current window?
Inside the rolling retention window, Watkins Tim bought $0 and sold $323K based on SEC Form 4 filings.
What was Watkins Tim's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,833 CTNM shares on 2026-06-30, worth $174K, per SEC Form 4 filings.